These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 28541019)
1. Amyloidosis and device therapy: an open debate. LA Franca E; Corrado E; Inga G; Ciaramitaro G; Novo S; Coppola G Int Angiol; 2017 Oct; 36(5):497-498. PubMed ID: 28541019 [No Abstract] [Full Text] [Related]
3. Implantable cardioverter defibrillators in patients with cardiac amyloidosis. Lin G; Dispenzieri A; Kyle R; Grogan M; Brady PA J Cardiovasc Electrophysiol; 2013 Jul; 24(7):793-8. PubMed ID: 23489983 [TBL] [Abstract][Full Text] [Related]
4. Symptomatic conduction system disease in cardiac amyloidosis. Mathew V; Olson LJ; Gertz MA; Hayes DL Am J Cardiol; 1997 Dec; 80(11):1491-2. PubMed ID: 9399732 [TBL] [Abstract][Full Text] [Related]
5. Successful termination of a ventricular arrhythmia by implantable cardioverter defibrillator therapy in a patient with cardiac amyloidosis: insight into mechanisms of sudden death. Lin G; Dispenzieri A; Brady PA Eur Heart J; 2010 Jun; 31(12):1538. PubMed ID: 20061577 [No Abstract] [Full Text] [Related]
6. Prophylactic implantation of cardioverter-defibrillator in patients with severe cardiac amyloidosis and high risk for sudden cardiac death. Kristen AV; Dengler TJ; Hegenbart U; Schonland SO; Goldschmidt H; Sack FU; Voss F; Becker R; Katus HA; Bauer A Heart Rhythm; 2008 Feb; 5(2):235-40. PubMed ID: 18242546 [TBL] [Abstract][Full Text] [Related]
11. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. Fruchter O N Engl J Med; 1998 Apr; 338(17):1227-8. PubMed ID: 9556392 [No Abstract] [Full Text] [Related]
12. Summaries for patients. Who benefits from implantable heart defibrillators? Ann Intern Med; 2003 Mar; 138(6):I40. PubMed ID: 12639107 [No Abstract] [Full Text] [Related]
15. The automatic implantable cardioverter-defibrillator: technology for preventing sudden cardiac death. Thakor NV; Natarajan A Med Des Mater; 1991 Mar; 1(3):16-24. PubMed ID: 10147992 [TBL] [Abstract][Full Text] [Related]
16. [Primary prevention of sudden cardiac death in 2003. Role of implantable automatic defibrillators]. Mélon P Rev Med Liege; 2003 Jun; 58(6):396-9. PubMed ID: 12945238 [TBL] [Abstract][Full Text] [Related]
17. Arrhythmogenic right ventricular dysplasia: from genetics to treatment. Khan A; Mittal S; Sherrid MV Anadolu Kardiyol Derg; 2009 Dec; 9 Suppl 2():24-31. PubMed ID: 20089484 [TBL] [Abstract][Full Text] [Related]